Valerie Morisset, EVP, R&D AND CSO at Eliem Therapeutics, Inc. (ELYM), sold 178,412 shares at $8.07 ($1.4M) on 2024-07-22, disclosed to the SEC on 2024-07-23.
Open-market sale of $1.4M ELYM by EVP, R&D AND CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.09 | 10,201 | $72K | 5.3% |
| 2 | $7.09 | 10,201 | $72K | 5.3% |
| 3 | $7.24 | 50,000 | $362K | 26.3% |
| 4 | $7.98 | 30,000 | $239K | 17.4% |
| 5 | $8.07 | 39,005 | $315K | 22.9% |
| 6 | $8.07 | 39,005 |
| $315K |
| 22.9% |
| Total | $7.71 avg | 178,412 | $1.4M | 100% |
| Filing → |
| ELYM | SELL | 2024-07-16 | $948K | — | Filing → |
| ELYM | SELL | 2024-07-11 | $737K | — | Filing → |
| ELYM | SELL | 2024-07-09 | $174K | — | Filing → |